Literature DB >> 24272771

M1 macrophages act as LTβR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis.

Kevin Guedj1, Jamila Khallou-Laschet, Marc Clement, Marion Morvan, Anh-Thu Gaston, Giulia Fornasa, Jianping Dai, Marianne Gervais-Taurel, Gerard Eberl, Jean-Baptiste Michel, Giuseppina Caligiuri, Antonino Nicoletti.   

Abstract

AIMS: The goal of this study was to characterize the role of inflammatory macrophages in the induction of the vascular smooth muscle cell (VSMC)-mediated formation of aortic tertiary lymphoid organs (TLOs). METHODS AND
RESULTS: Mouse bone marrow-derived M1 macrophages acted as lymphoid tissue inducer cells. Indeed, they expressed high levels of tumour necrosis factor (TNF)-α and membrane-bound lymphotoxin (LT)-α, two inducing cytokines that triggered expression of the chemokines CCL19, CCL20, and CXCL16, as did M1 supernatant. The blockade of LTβR signalling with LTβR-Ig had no effect, whereas that of TNFR1/2 signalling reduced chemokine expression by VSMCs in both wild-type (WT) and LTβR KO mice, demonstrating that LTβR signalling is dispensable for the M1-inducing effect. This effect was corroborated by the development of TLOs observed in LTβR KO->apolipoprotein E knockout (ApoE KO) aortic segments after orthotopic transplantation. Furthermore, treatment of ApoE KO mice with anti-TNF-α antibody decreased the number and incidence of aortic TLOs. Finally, lymphoid nodules composed of T and B cells formed in in vivo-implanted scaffolds seeded with VSMCs previously stimulated ex vivo by M1-conditioned medium.
CONCLUSIONS: These results are the first to identify M1 macrophages as inducer cells that trigger the expression of chemokines by VSMCs independently of LTβR signalling. We propose that the dialogue between macrophages and VSMCs-established across the vascular wall-contributes to the formation of aortic TLOs.

Entities:  

Keywords:  Atherosclerosis; Chemokine; Lymphocyte; Macrophage; Smooth muscle cell

Mesh:

Substances:

Year:  2013        PMID: 24272771     DOI: 10.1093/cvr/cvt263

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  26 in total

Review 1.  Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity.

Authors:  Victor H Engelhard; Anthony B Rodriguez; Ileana S Mauldin; Amber N Woods; J David Peske; Craig L Slingluff
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

2.  Regulation of Notch 1 signaling in THP-1 cells enhances M2 macrophage differentiation.

Authors:  Reetu D Singla; Jing Wang; Dinender K Singla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-26       Impact factor: 4.733

Review 3.  Modulators of microglial activation and polarization after intracerebral haemorrhage.

Authors:  Xi Lan; Xiaoning Han; Qian Li; Qing-Wu Yang; Jian Wang
Journal:  Nat Rev Neurol       Date:  2017-05-19       Impact factor: 42.937

Review 4.  From genetics to response to injury: vascular smooth muscle cells in aneurysms and dissections of the ascending aorta.

Authors:  Jean-Baptiste Michel; Guillaume Jondeau; Dianna M Milewicz
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

5.  Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer.

Authors:  Aliyah M Weinstein; Nicolas A Giraldo; Florent Petitprez; Catherine Julie; Laetitia Lacroix; Frédérique Peschaud; Jean-François Emile; Laetitia Marisa; Wolf H Fridman; Walter J Storkus; Catherine Sautès-Fridman
Journal:  Cancer Immunol Immunother       Date:  2018-10-12       Impact factor: 6.968

Review 6.  The Role of Lymphoid Neogenesis in Allografts.

Authors:  H-M Hsiao; W Li; A E Gelman; A S Krupnick; D Kreisel
Journal:  Am J Transplant       Date:  2016-02-15       Impact factor: 8.086

7.  De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors.

Authors:  Anna Johansson-Percival; Bo He; Zhi-Jie Li; Alva Kjellén; Karen Russell; Ji Li; Irma Larma; Ruth Ganss
Journal:  Nat Immunol       Date:  2017-09-11       Impact factor: 25.606

Review 8.  Once Upon a Time: The Adaptive Immune Response in Atherosclerosis--a Fairy Tale No More.

Authors:  Marie Le Borgne; Giuseppina Caligiuri; Antonino Nicoletti
Journal:  Mol Med       Date:  2015-10-27       Impact factor: 6.354

Review 9.  Tertiary lymphoid structures in the era of cancer immunotherapy.

Authors:  Catherine Sautès-Fridman; Florent Petitprez; Julien Calderaro; Wolf Herman Fridman
Journal:  Nat Rev Cancer       Date:  2019-06       Impact factor: 60.716

Review 10.  Tumor-infiltrating lymphocytes in the immunotherapy era.

Authors:  Sterre T Paijens; Annegé Vledder; Marco de Bruyn; Hans W Nijman
Journal:  Cell Mol Immunol       Date:  2020-11-02       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.